2nd Quarter - Report

BOCKORNY GROUP, INC. for GLAXOSMITHKLINE

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmaceutical import safety legislation Implementation of the Patient Protection and Affordable Health Care Act H.R. 5651, Food and Drug Administration Reform Act of 2012 S. 3187, Food and Drug Administration Safety and Innovation Act

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
ANDREW CHARLES DODSON —
BRENDA REESE —
MELISSA SCHULMAN —
MICHAELA SIMS —
TYLER THOMPSON —
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5651 (112th), S. 3187 (112th)

Budget/Appropriations BUD

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013

LobbyistCovered position, as disclosed
TYLER THOMPSON —
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Foreign Relations FOR

Global Health Initiatives

LobbyistCovered position, as disclosed
MELISSA SCHULMAN —
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare Drug Benefit

LobbyistCovered position, as disclosed
DAVID BOCKORNY —
BLAIR C LARKINS —
BRENDA REESE —
MELISSA SCHULMAN —
MICHAELA SIMS —
TYLER THOMPSON —
NICOLE VENABLE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.